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Objective: To assess the role of progesterone (P) on [human chorionic gonadotropin (hCG) day]/oocyte
ratio rather than a single cut-off value of serum P on hCG day to predict in vitro fertilization (IVF) outcomes.
Materials and Methods: A Retrospective, single center, cohort study in 687 infertile women undergoing
fresh IVF/intracytoplasmic sperm injection (ICSI) treatment with long agonist protocol. The data was
categorized into three groups according to serum P levels (Group A < 1.0, Group B: 1.0e1.5, Group
C  1.5) and two groups on the basis of P/oocyte ratio (Group A  0.15; Group B > 0.15) determined using
receiver operating characteristic (ROC). For comparing categorical data, c2/Fishers exact test was carried
out as appropriate. ROC analysis was performed to determine cut-off value for P and P/oocyte, which may
discriminate between pregnancy and nonpregnancy.
Results: The mean age of participants was 31.6 ± 3.7 years and overall pregnancy rate was 26.1%.
Elevation of both serum P levels and P/oocyte ratio was found to signiﬁcantly reduce the pregnancy
potential in IVF without affecting fertilization and cleavage rates. The detrimental cut-off value for P and
P/oocyte was found to be >1.0 ng/mL (sensitivity 56%; speciﬁcity 52%) and >0.15 (sensitivity 62%;
speciﬁcity 61%) respectively. Pregnancy rate (35.3%) among the patients having 0.15 P/oocyte ratio was
signiﬁcantly higher (p < 0.001) compared with 18.8% observed among the patients having value >0.15.
Conclusion: P/oocyte ratio may be considered as a valuable tool to predict IVF outcomes when compared
with serum P levels alone, but more evidence from randomized studies is required.
Copyright © 2016, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
The effect of elevated serum progesterone (P) on day of human
chorionic gonadotropin (hCG) administration on in vitro fertiliza-
tion (IVF) outcome is still a matter of debate. It has been shown in a
large number of studies that elevated serum P has a deleterious
effect on pregnancy outcome of IVF cycles [1e6], while other
studies have denied such an association [7e9]. The mechanism of
this elevation of serum P on hCG day is still not clear. However, a
number of factors inﬂuencing the serum P concentration have been
found. The number of follicles and follicular stimulating hormone
(FSH) drive have been found to be positively associated with raised
P levels [10]. It has also been reported that the level of P elevation
varies with type of ovarian response [11].Teaching Block, 3rd Floor,
nstitute of Medical Sciences,
h).
bstetrics & Gynecology. Published bDifferent cut-off valuesof serumP levels thatwouldbeconsidered
asdetrimental for pregnancyoutcome in IVF havebeenproposed in a
number of studies. Considering the relationship between serum P
and follicle number, itwould be better to use ratio of serumP on hCG
day to the number of oocytes retrieved (P/oocyte ratio) rather than a
single cut-off value of P to predict pregnancy outcome in IVF. The
number of studies evaluating P/oocyte ratio as a tool for prediction of
pregnancyoutcomeare very limited. Thus,we tried to investigate the
relationship between serum P on day of hCG administration and P/
oocyte ratio with the pregnancy outcome in gonadotropin releasing
hormone (GnRH) long agonist protocol in nondonor fresh IVF/
intracytoplasmic sperm injection (ICSI) cycles in this study.Materials and methods
This was a single-center retrospective cohort study of patients
undergoing IVF/ICSI treatment from January 2012 to July 2014 at
the assisted reproductive technology center of the All India Insti-
tute of Medical Sciences, New Delhi. Complete data of 687 womeny Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Table 1
Baseline characteristics of patients.
Characteristics Overall
No. of patients (n) 687
Age (y) 31.6 ± 3.7
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protocol was reviewed. Exclusion criteria were as follows: age >
40 years, antimullerian hormone < 1.0 ng/mL, and frozen embryo
transfer (FET) cycles. The main outcome measure was the effect of
serum P and P/oocyte ratio on pregnancy outcome.BMI (kg/m2) 25.4 ± 4.0
FSH(follicular phase) (mIU/mL) 6.0 ± 1.9
LH (mIU/mL) 4.2 ± 2.4
AMH (ng/mL) 3.2 ± 1.6
Total AFC 5.9 ± 2.3
Total gonadotropin dose (IU) 3498 ± 1118
Endometrial thickness (on hCG day) (mm) 9.5 ± 1.7
E2 on hCG day (pg/mL) 3655.5 ± 2391.5
P on hCG day (ng/mL) 1.27 ± 0.8
Clinical indications:




Male factor (%) 8
Unexplained (%) 12
Multiple factors (%) 11
AFC¼ antral follicle count; AMH¼ antimullerian hormone; BMI¼ bodymass index;
DOR ¼ Diminished Ovarian Reserve; FSH ¼ follicular stimulating hormone;
hCG ¼ human chorionic gonadotropin; LH ¼ luteinizing hormone;
P ¼ progesterone; PCOS ¼ Polycystic Ovarian Syndrome.
Table 2
Treatment outcome of in vitro fertilization/intracytoplasmic sperm injection
cycles.
Characteristics Overall
(n ¼ 681 cycles)
No. of mature oocytes retrieved 7.2 ± 3.9
P/oocyte ratio 0.24 ± 0.27
Cleavage rate (%) 88.7
No. of embryos transferred 2.8 ± 0.8
Fertilization rate (%) 86.5
Pregnancy rate (%) 26.1
P ¼ progesterone.Stimulation protocol
Patients underwent controlled ovarian hyperstimulation (COH)
with use of a GnRH agonist long protocol. The pituitary down-
regulation was achieved by subcutaneous injection of 1 mg of
leuprolide acetate daily from the midluteal phase of the preceding
cycle. Ovarian stimulationwas done with 150e300 IU recombinant
FSH follitropin alpha (Gonal F, Merck Serono, Darmstadt, Germany)
subcutaneously and dose adjusted according to the response. Re-
combinant chorionic gonadotropin alpha (250 mg; Ovitrelle, Merck
Biopharma, Darmstadt, Germany) was given to trigger ovulation
when at least two to three leading follicles reached a mean diam-
eter of 18 mm. Serum P and E2 levels were measured on the day of
hCG administration by the chemiluminescent immunoassay using
the Access 2 immunoassay system (Beckman Coulter, California,
United States). Endometrial thickness was also recorded on trans-
vaginal ultrasound. Oocyte pickup was done 36 hours after hCG
administration. Oocytes were cultured in G-IVF plus media (Vitro-
life, Sweden) containing 10% of human serum albumin with
gentamicin as an antibacterial agent and inseminated with motile
sperm prepared by the two-layer Percoll gradient method. Fertil-
ization was deﬁned as oocytes with two pronuclei 16e20 hours
after insemination. Embryos were transferred to G-IVF plus media
and were classiﬁed by blastomere equalization and cytoplasmic
fragment. Day 3 or Day 5 embryo transfer was done depending
upon the number of embryos and excess good-quality embryos
were cryopreserved for subsequent FET cycles. An ongoing preg-
nancywas deﬁned as a pregnancy test done after 14 days of embryo
transfer with a positive heartbeat by ultrasound at 6 weeks of
gestation.
Three groups were made according to serum P levels: Group
A < 1.0, Group B 1.0e1.5, and Group C  1.5.
Two groups were made according to P/oocyte ratio as deter-
mined by ROC analysis: Group A  0.15, and Group B > 0.15.
All statistical analysis was carried out using SPSS, IBM version 19
(Armonk, NY: IBM Corp). Data was expressed as mean, standard
deviation or frequencies, and percentages. For comparing categor-
ical data, c2/Fishers exact test was carried out as appropriate. ROC
analysis was performed to determine cut-off value for P and P/
oocyte at an approximately equivalent sensitivity and speciﬁcity,
which may discriminate between pregnancy and nonpregnancy. A
value p < 0.05 was considered to be statistically signiﬁcant.Table 3











Fertilization rate (%) 84.3 84.8 83.8 NS
Cleavage rate (%) 89.8 89.4 88.3 NS
Pregnancy rate (%) 30.8 28.2 16.6 0.003
NS ¼ not signiﬁcant.Results
A total of 687 ovarian stimulation cycles were included in the
study. Out of these, six cycles needed to be cancelled, as no oocyte
could be retrieved. Out of the remaining 681 cycles, 64.9% (n¼ 442)
were conventional IVF cycles while 35.0% (n ¼ 239) were ICSI cy-
cles. Baseline characteristics such as age, body mass index, FSH,
luteinizing hormone (follicular phase), antimullerian hormone,
total antral follicle count, total gonadotropin dose, endometrial
thickness, E2, P on day of hCG, and clinical indications for IVF-
Embryo transfer (ET) are as presented in Table 1.
The pregnancy outcomes including the number of oocytes
retrieved, fertilization rate, cleavage rate, pregnancy rate, P/oocyte
ratio, and number of transferred embryos for all of the women are
shown in Table 2.We analyzed the correlation between the serum P levels and the
fertilization rate, cleavage rate, and pregnancy rate among the three
groups made according to serum P levels (Group A  1.0, Group B
1.0e1.5, Group C  1.5) as shown in Table 3. It was found that
pregnancy rate had a signiﬁcantly decreasing trend (c2 trend in
proportion¼ 11.6; p¼ 0.003) with increasing levels of serum Pwith
no effect on fertilization and cleavage rate.
To determine an optimal detrimental threshold of P levels, ROC
analysis was used. The area under curve (AUC) 0.58 (95% conﬁdence
interval: 0.53e0.63) was found to be signiﬁcant (p ¼ 0.002). The
cut-off value of serum P on hCG day was found to be 1.00 for
sensitivity and speciﬁcity value of 56% and 52%, respectively
(Figure 1).
As the adverse effect of serum P on pregnancy outcome varies
according to the type of ovarian response, thus we calculated a cut-
off value of P/oocyte ratio to be used as a predictor for IVF outcome
rather than P levels alone.
Figure 1. Receiver operating characteristic (ROC) curve for deﬁning optimal detri-
mental cut-off value for progesterone (P) on human chorionic gonadotropin (hCG) day.
Table 4








Fertilization rate (%) 85.9 87.2 1.78 (0.182)
Cleavage rate (%) 89.5 87.7 3.15 (0.076)
Pregnancy rate (%) 35.3 18.8 23.8 (0.000)
N. Singh et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 503e506 505Using ROC, we determined a cut-off level of 0.15 for P/oocyte
ratio (AUC: 0.58; p < 0.001) with sensitivity and speciﬁcity of 62%
and 61%, respectively (Figure 2).
The fertilization, cleavage and pregnancy rate were compared in
two groups made according to P/oocyte levels as shown in Table 4.Figure 2. Receiver operating characteristic (ROC) curve for deﬁning optimal detri-
mental cut-off value for progesterone (P)/oocyte ratio.Pregnancy rate (35.3%) among the patients having 0.15 P/
oocyte ratio was signiﬁcantly higher (p < 0.001) compared with
18.8% observed among the patients having value >0.15. However,
fertilization and cleavage rates were not signiﬁcantly different
(p > 0.05) between the two categories.
Discussion
The number of follicles is considered to be one of the important
factors that inﬂuences the concentration of serum P during COH
[12]. Considering this fact, this study has suggested that not only
the P levels, but also the ratio of serum P on hCG day to the number
of oocytes retrieved can be used as a tool to prognosticate IVF
outcome. It was found that both serum P levels and P/oocyte ratio
have a negative association with pregnancy rate beyond a cut-off
value of 1.00 ng/mL and 0.15 ng/mL, respectively, with no effect
on fertilization and cleavage rate.
The issue of P elevation and its effect on pregnancy outcome in
IVF is still unresolved. Despite the use of GnRH agonists and an-
tagonists to prevent luteinizing hormone surge, serum P elevation
at time of hCG administration has been reported in as high as 35%
(5e35%) of stimulated cycles with GnRH agonists and 38%
(20e38%) of cycles with GnRH antagonists [1,13]. The underlying
mechanism of this P elevation and its effect on IVF outcome is still
controversial.
Until now, numerous studies evaluating the role of P elevation
on pregnancy outcome have been published. A recent meta-
analysis and systematic review of over 60,000 IVF cycles by Ven-
etis et al [14] showed that P elevation on day of hCG administration
is associated with a signiﬁcantly decreased probability of preg-
nancy in fresh IVF cycles using gonadotropins and GnRH analogues
for ovarian stimulation. Different threshold values of P elevation,
that would be considered as detrimental for occurrence of preg-
nancy, have been proposed in a number of studies, and vary from
0.9 ng/mL to 3 ng/mL [7,15]. The results of this study were also in
agreement with it and found a detrimental cut-off value of >1.0 ng/
mL for serum P elevation.
However, serum P levels alone may not be a good predictor for
probability of pregnancy, as it is inﬂuenced by a number of other
factors. Recently, the rise of serum P has been found to be related to
multiple follicular development and increased ovarian steroido-
genic activity occurring during COH [12,15,16]. The recent meta-
analysis in 2013 also showed that the number of retrieved oo-
cytes, E2 levels on day of hCG, and total amount of FSH dose
required for ovarian stimulation appeared to be increased signiﬁ-
cantly in women with P elevation when compared with those
without P elevation [14].
The potential effect of P elevation and its negative effect on
pregnancy outcome vary according to the type of ovarian response.
In an analysis ofmore than 10,000 cycles carried out by Xu et al [11],
different threshold values for serum P levels were determined
among different ovarian responders: 1.5 ng/mL for poor re-
sponders, 1.75 ng/mL for intermediate responders, and 2.25 ng/mL
for high responders. Therefore, P/oocyte ratio seems to be a better
option to predict pregnancy outcome as compared with P levels
alone.
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evaluating the role of P/oocyte ratio to prognosticate the outcome
of IVF treatment. In an earlier retrospective study carried out by
Burns et al [17] in 114 IVF cycles, P/oocyte ratios were found to be
inversely associated with clinical pregnancy (p < 0.05) and
ongoing/delivered pregnancy (p < 0.02) for both the day of and the
day after hCG. In a recent study by Aﬂatoonian et al [18], it was
found that P per metaphase II oocyte was better than absolute P
value and P/E2 ratio for predicting the pregnancy and fertilization
rate. A cut-off value of >0.32 for P/oocyte was considered to be
related adversely with pregnancy rate. We used ROC analysis to
identify optimal thresholds of P/oocyte to deﬁne these detrimental
cut-offs and the value was found to be 0.15.
It has been proposed in a number of studies that the adverse
effect of P elevation on pregnancy may be due to impairment of
endometrial receptivity and not the oocyte/embryo quality
[11,19,20]. The present study also supports this opinion as the
fertilization and cleavage rate were not found to be affected with
elevation of either P or P/oocyte ratio.
In conclusion, the present study shows that elevation of either P
or P/oocyte ratio are inversely associated with probability of
pregnancy. P/oocyte ratio may be considered as an important and
better tool to predict IVF outcomes as compared with serum P
levels alone. As this study is limited by its retrospective design,
future randomized trials are required to evaluate the role of P/
pocyte ratio as a valuable prognostic tool in IVF over P levels alone.
Conﬂicts of interest
The authors have no conﬂict of interest relevant to this article.
Acknowledgments
We acknowledge all the colleagues who supported us while
conducting this study.
References
[1] Wu Ze, Li Rong, Ma Yanping, Deng Bo, Zhang Xiaomei, Meng Yushi, et al. Effect
of HCG-day serum progesterone and oestradiol concentrations on pregnancy
outcomes in GnRH agonist cycles. Reprod Biomed Online 2012;24:511e20.
[2] Al-Azemi M, Kyrou D, Kolibianakis EM, Humaidan P, Van Vaerenbergh I,
Devroey P, et al. Elevated progesterone during ovarian stimulation for IVF.
Reproductive Biomed Online 2012;24:381e8.
[3] Bosch E, Labarta E, Crespo J, Simon C, Remohí J, Jenkins J, et al. Circulating
progesterone levels and ongoing pregnancy rates in controlled ovarianstimulation cycles for in vitro fertilization: analysis of over 4000 cycles. Hum
Reprod 2010;25:2092e100.
[4] Shulman A, Ghetler Y, Beyth Y, Ben-Nun I. The signiﬁcance of an early (pre-
mature) rise of plasma P in in vitro fertilization cycles induced by a “long
protocol” of gonadotropin releasing hormone analogue and human meno-
pausal gonadotropins. J Assist Reprod Genet 1996;13:207e11.
[5] Fanchin R, de Ziegler D, Taieb J, Hazout A, Frydman R. Premature elevation of
plasma P alters pregnancy rates of in vitro fertilization and embryo transfer.
Fertil Steril 1993;59:1090e4.
[6] Ochsenkühn R, Arzberger A, von Sch€onfeldt V, Gallwas J, Rogenhofer N,
Crispin A, et al. Subtle progesterone rise on the day of human chorionic
gonadotropin administration is associated with lower live birth rates in
women undergoing assisted reproductive technology: a retrospective study
with 2,555 fresh embryo transfers. Fertil Steril 2012;98:347e54.
[7] Martinez F, Coroleu B, Clua E, Tur R, Buxaderas R, Parera N, et al. Serum P
concentrations on the day of hCG administration cannot predict pregnancy in
assisted reproduction cycles. Reprod Biomed Online 2004;8:183e90.
[8] Urman B, Alatas C, Aksoy S, Mercan R, Isiklar A, Balaban B. Elevated serum P
level on the day of human chorionic gonadotropin administration does not
adversely affect implantation rates after intracytoplasmic sperm injection and
embryo transfer. Fertil Steril 1999;72:975e9.
[9] Andersen CY, Bungum L, Andersen AN, Humaidan P. Preovulatory progester-
one concentration associates signiﬁcantly to follicle number and LH concen-
tration but not to pregnancy rate. Reprod Biomed Online 2011;23:187e95.
[10] Andersen AN, Devroey P, Arce JC. Clinical outcome following stimulation with
highly puriﬁed hMG or recombinant FSH in patients undergoing IVF: a ran-
domized assessor-blind controlled trial. Hum Reprod 2006;21:3217e27.
[11] Xu B, Li Z, Zhang H, Jin L, Li Y, Ai J, et al. Serum progesterone level effects on
the outcome of in vitro fertilization in patients with different ovarian
response: An analysis of more than 10,000 cycles. Fertil Steril 2012;97.
1321e1327.e1324.
[12] Fleming R, Jenkins J. The source and implications of P rise during the follicular
phase of assisted reproduction cycles. Reprod Biomed Online 2010;21:446e9.
[13] Check JH, Chase JS, Nowroozi K, Dietterich CJ. Premature luteinization:
treatment and incidence in natural cycles. Hum Reprod 1991;6:190e3.
[14] Venetis CA, Kolibianakis EM, Bosdou JK, Tarlatzis BC. Progesterone elevation
and probability of pregnancy after IVF: a systematic review and meta-analysis
of over 60 000 cycles. Hum Reprod Update 2013;19:433e57.
[15] Bosch E, Valencia W, Escudero E, Crespo J, Simon C, Remohi J, et al. Premature
luteinization during gonadotropin-releasing hormone antagonist cycles and
its relationship with in vitro fertilization outcome. Fertil Steril 2003;80:
1444e9.
[16] Harada T, Katagiri C, Takao N, Toda T, Mio Y, Terakawa N. Altering the timing
of human chorionic gonadotropin injection according to serum P concentra-
tions improves embryo quality in cycles with subtle P rise. Fertil Steril
1996;65:594e7.
[17] Burns WN, Witz CA, Klein NA, Silverberg KM, Schenken RS. Serum proges-
terone concentrations on the day after human chorionic gonadotropin
administration and progesterone/oocyte ratios predict in-vitro fertilization/
embryo transfer outcome. J Assist Reprod Genet 1994;11:17e23.
[18] Aﬂatoonian A, Davar R, Hojjat F. Elevated serum progesterone/MII oocyte ratio
on the day of human chorionic gonadotropin administration can predict
impaired endometrial receptivity. Iran J Reprod Med 2014;12:427e34.
[19] Bourgain C, Devroey P. The endometrium in stimulated cycles for IVF. Hum
Reprod Update 2003;9:515e22.
[20] Huang R, Fang C, Xu S, Yi Y, Liang X. Premature progesterone rise negatively
correlated with live birth rate in IVF cycles with GnRH agonist: an analysis of
2,566 cycles. Fertil Steril 2012;98:664e70.
